The Pfizer Clinical Research Unit in New Haven is conducting a study of an oral study drug for heart failure. The purpose of this study is to assess the effects of multiple doses of the study drug when given to healthy volunteers.
Heart failure happens when the heart cannot pump enough blood and oxygen throughout the body. This is often the result of an underlying illness and can be a serious or even life-threatening condition. There is currently no cure for heart failure and patients are in need of effective treatment options.
Read more about this study below and see how you can help patients as a healthy volunteer.
Who may participate
Clinical trial volunteers are an important part of drug development and can help change the world for patients.
This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:
- Willing to take a study drug
- Willing and able to come to our facility in New Haven, CT*
- For Japanese participants only: must have 4 biologically Japanese grandparents born in Japan
*participants may be eligible to receive a bonus for travel, ask our staff for details
**females must be unable to bear children
There are other requirements for participation in this study. The study staff will explain these to you during the screening process.
Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus.
Condition
Healthy
Age
18-60 years
Sex
All sexes**
Referral bonus
Up to $175
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
If this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing.
If you choose to participate, you will stay at our facility up to 18 overnights. Starting the second morning after admission, you will receive up to 2 oral doses of the study drug daily for 14 days. On the last day, you will receive only a single dose in the morning, for a total of up to 27 doses. All doses are given as a liquid to swallow after a meal or snack.
Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood and urine.
Required overnight stays
18
Long-term follow up
1 visit + 1 phone call
How long is this study?
Up to about 44 days
Compensation
Up to $6,410 upon completion of the study*
All of the study procedures will be clearly explained to you during screening and can be viewed by downloading the informed consent form.
The PCRU Loyalty Program has arrived!
Our new Loyalty Program offers unique tiered gifts for new and returning participants.
Interested in participating?
Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you. Please note: volunteers completing this form must be able to read and speak English at an 8th grade level.
You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.
For Japanese language assistance only, please call 1-833-711-9984. We apologize, our representatives cannot take calls in languages other than English or Japanese at this time.
The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.